𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients

✍ Scribed by F. J. Peñalver; V. Jimenez-Yuste; M. Almagro; A. Alvarez-Larrán; L. Rodríguez; M. Casado; L. Gallur; P. Giraldo; R. Hernández; D. Menor; M. J. Rodríguez; D. Caballero; R. González; J. Mayans; I. Millán; J. R. Cabrera; On behalf of the Multi-institutional Retrospective Spanish Study on the use of rituximab in refractory ITP

Publisher
Springer
Year
2006
Tongue
English
Weight
48 KB
Volume
85
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent thrombotic thrombocytopenic p
Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an HIV-positive patient: Case report and review of the literature
✍ Yospur, Lisa S.; Sun, Nora C.J.; Figueroa, Priscilla; Niihara, Yutaka 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 2 views

Immune thrombocytopenlc purpura (ITP) and thrombotic thrombocytopenlc purpura (lTP) have each been associated with HIV Infection. Sequential occurrence of these two dlseases with a disease-free interval has been occasionally reported In the literature, whereas simultaneous manifestations of these tw